The aim of the study was the development of three-dimensional (3D) printed gene-activated implants based on octacalcium phosphate (OCP) and plasmid DNA encoding VEGFA. The first objective of the present work involved design and fabrication of gene-activated bone substitutes based on the OCP and plasmid DNA with VEGFА gene using 3D printing approach of ceramic constructs, providing the control of its architectonics compliance to the initial digital models. X-ray diffraction, scanning electron microscopy (SEM), Fourier transform infrared spectroscopy, and compressive strength analyses were applied to investigate the chemical composition, microstructure, and mechanical properties of the experimental samples. The biodegradation rate and the efficacy of plasmid DNA delivery in vivo were assessed during standard tests with subcutaneous implantation to rodents in the next stage. The final part of the study involved substitution of segmental tibia and mandibular defects in adult pigs with 3D printed gene-activated implants. Biodegradation, osteointegration, and effectiveness of a reparative osteogenesis were evaluated with computerized tomography, SEM, and a histological examination. The combination of gene therapy and 3D printed implants manifested the significant clinical potential for effective bone regeneration in large/critical size defect cases.
A new silanediamine ligand L 2− bearing planar Ph-benzothiazole groups gives complexes [LnL 2 ] − with larger Ln cations (La, Nd, Gd, Y), and [HoLCl 2 Li(thf) 2 ]. Their luminescence was investigated, and the triplet state energy of the ligand was estimated.
The range of lanthanide complexes with bulky N,N′-bis(Dipp)-substituted β-diketiminate ligand Nacnac− = CH(CMe(NDipp))2− (Dipp = 2,6-diisopropylphenyl) has been expanded to the complexes [Ln(Nacnac)I2(thf)n] (1Ln, Ln = Gd, Tb, n = 2; Dy, n = 1; thf = tetrahydrofuran). They were further used in salt metathesis reactions with KSPh and KS(2-Py) (2-Py = 2-pyridyl), resulting in thiolato complexes [Ln(Nacnac)(SPh)2(thf)] (2Ln) and [Ln(Nacnac)(SPy)2] (3Ln). As an analogue of 2Tb without coordinated thf molecules, binuclear complex [{Tb(Nacnac)(SPh)}2(μ-SPh)2] (4Tb) was obtained by reaction of dry TbI3 with K(Nacnac) and KSPh in Et2O followed by recrystallization from toluene. The diiodo complexes possess different numbers of coordinated thf molecules and different coordination polyhedra owing to the lanthanide contraction. On the contrary, all 2Ln and 3Ln have the same molecular and crystal structures for a given thiolate, owing to the coordination rigidity provided by edge coordination of a Ph cycle or by chelating binding of a S(2-Py)− ligand. UV-vis and photoluminescence spectra were registered for all compounds. A triplet level of the Nacnac− ligand of 2.22 × 104 cm−1 was determined from the solid-state emission of Gd complex 1Gd at 77 K; the triplet level in 2Gd and 3Gd was found at 2.16 × 104 cm−1. Emission lifetimes and quantum yields were measured for all Tb compounds with the highest values for thiolato complexes 2Tb and 3Tb, while 1Tb showed only weak emission. The relationship of the emission properties with the molecular and crystal structures is discussed, and better antenna properties are proposed for thiolato rather than for Nacnac− ligands.
The possibilities of the ion exchange reactions between the neodymium(III) and samarium(III) diiodo-β-diketiminate complexes [Ln(Nacnac)I2(Тhf)2] (Ln = Nd (I), Sm (II); Nacnac is HC\(\left\{ {{\text{C}}\left( {{\text{Me}}} \right){\text{N}}\left( {{\text{2}},{\text{6}} - {{{\text{C}}}_{{\text{6}}}}{\text{H}}_{{\text{4}}}^{i}{\text{P}}{{{\text{r}}}_{{\text{2}}}}} \right)} \right\}_{{\text{2}}}^{-};\) Thf is tetrahydrofuran) and potassium mono- and dichalcogenides K2Qn (Q = S, Se, Te; n = 1, 2) in Thf are studied. The ion exchange of iodide ligands by dichalcogenide ligands does not occur under these conditions. The reaction of complex I with K2Se affords the divalent samarium complex [Sm(Nacnac)I(Thf)2] (III). The sequence of the steps leading to the formation of this complex, including the reduction of the sterically hindered bis(diketiminate) complex, is proposed.